Published in

Wiley, Journal of Thrombosis and Haemostasis, 10(10), p. 2123-2126, 2012

DOI: 10.1111/j.1538-7836.2012.04912.x

Links

Tools

Export citation

Search in Google Scholar

Antithrombotic phosphoinositide 3-kinase β inhibitors in humans: A 'shear' delight!

Journal article published in 2012 by S. P. Jackson, S. M. Schoenwaelder ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Jackson SP, Schoenwaelder SM. Antithrombotic phosphoinositide 3-kinase β inhibitors in humans: a 'shear' delight!J Thromb Haemost 2012; 10: 2123-6.See also Nylander S, Kull B, Bjorkman JA, Ulvinge J-C, Oakes N, Emanuelsson BM, Andersson M, Skarby T, Inghardt T, Fjellstrom O, Gustafsson D. Human target validation of phosphoinositide 3-kinase (PI3K)β:effects on platelets and insulin sensitivity, using AZD6482 a novel PI3Kβ inhibitor. This issue, pp 2127-36.